Nuformix plc

Company Profile

Company website
Pharmaceuticals and Biotechnology (Biotechnology)
Nuformix plc (LSE: NFX) is a pharmaceutical development company targeting unmet medical needs in fibrosis and oncology via drug repurposing. The Company has an early-stage pipeline of preclinical and Phase 1-ready assets with potential for significant value and early licensing opportunities.

Investor Access

Event information

There is no Investor Access event planned at the moment - click on "Register your Interest" and we'll tell the Company that you'd like to attend one in the future and update you when an event is planned.

Financial Calendar
Event Date
Year End31 March
Half  Year End30 September
Preliminary Results*July
Interim Results*December

* Months based on previous announcements of this kind